Yungjin Pharm.

영진약품KRX: 003520· Fiscal year 2025· yungjin.co.kr ↗

Average salary
$51.9K
₩69.2M
▲ 6.0% vs 2024
Employees
626
▼ 0.3% vs 2024
Average tenure
Not disclosed

Estimated take-home of this pay:$3.5K / monthCalculate →

Workplace

Women's pay (men = 100)86
Women among staff30.7%
Contract staff6.7%

Recent official filings

Quick read

  • Average pay is 13% above the median of the companies we track.
  • Average pay rose 6.0% from 2024.
  • Headcount shrank by 2 (0.3%) from 2024.
  • Ranks #50 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 0.9% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 1.3% in 2025.

Last 3 years

Revenue
$176.3M2023$189.2M2024$190.9M2025
Operating income
$2.3M2023$6.5M2024$2.6M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$304.1K
Net profit per employee
-$272
Operating margin
1.3%
Net margin
-0.1%
ROE
-0.2%
Debt-to-equity
186.9%
Equity ratio
34.9%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.